This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jun 26;8(8):432.

doi: 10.1038/nrneph.2012.120.

Transplantation: Tofacitinib safe and effective in renal transplant recipients

PMID: 22735765
DOI: 10.1038/nrneph.2012.120

Comment

Transplantation: Tofacitinib safe and effective in renal transplant recipients

Helene Myrvang. Nat Rev Nephrol. 2012.

. 2012 Jun 26;8(8):432.

doi: 10.1038/nrneph.2012.120.

Author

PMID: 22735765
DOI: 10.1038/nrneph.2012.120

No abstract available

PubMed Disclaimer

Comment on

Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year.
Vincenti F, Tedesco Silva H, Busque S, O'Connell P, Friedewald J, Cibrik D, Budde K, Yoshida A, Cohney S, Weimar W, Kim YS, Lawendy N, Lan SP, Kudlacz E, Krishnaswami S, Chan G. Vincenti F, et al. Am J Transplant. 2012 Sep;12(9):2446-56. doi: 10.1111/j.1600-6143.2012.04127.x. Epub 2012 Jun 8. Am J Transplant. 2012. PMID: 22682022 Clinical Trial.

References

1. Am J Transplant. 2012 Sep;12(9):2446-56 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.